Events

Alerte De Sécurité sur Xpert BCR-ABL Monitor Technical Name: Chromosomal Translocation BCR-ABL Registration Number ANVISA: 81062710016 Hazard Class: III Affected Models: Kit with 10 tests (cartridges with integrated reaction tubes) Serial numbers affected: 1000040993

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par CEPHEID BRASIL IMPORTAÇÃO, EXPORTAÇÃO E COMÉRCIO DE PRODUTOS DE DIGANÓSTICOS LTDA.; CEPHEID.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    2207
  • Date
    2017-02-15
  • Pays de l'événement
    Brazil
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
    http://www.anvisa.gov.br/sistec/alerta/consultaralerta.asp
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    The proposed action to address device failures is to send customers a Field Security Notification (FSN), which informs customers to stop using the BCR-ABL Monitor product, lot 1000040993, which will later be collected by the company.
  • Cause
    A new test method for bcr-abl monitor shows that performance deteriorates after 12 months when stored at 2-28 ° c. the d10939 rev k stability report reduces the stability validity from 24 months to 12 months for the xpert bcr-abl monitor products. analysis of the mode of failure of bcr-abl in relation to the impact of the product result on the patient: stability data from the assay beyond 13 months sub-reported the amount of bcr-abl mrna transcript at the lowest level tested, 1%. the reported performance of the xpert bcr-abl monitor assay allows a 2-fold variance in the ratio of bcr-abl mrna transcripts to abl, considering that at 25 months, we observed a 3-fold difference. at 13 months, a variance of 1.8 times was observed, which is within the variability of performance of the declared product. although beyond the stability limits, the detected level of transcription of bcr-abl mrna is correctly termed as the bcr-abl detected.
  • Action
    Campo Action Code CPHD-001/2017 triggered under the responsibility of CEPHEID BRASIL IMPORT, EXPORT AND TRADE OF PRODUCTS OF DIGANÓSTICOS LTDA. Company will collect.

Device

Xpert BCR-ABL Monitor Technical Name: Chromosomal Translocation BCR-ABL Registration Number ANVIS...

Manufacturer

CEPHEID BRASIL IMPORTAÇÃO, EXPORTAÇÃO E COMÉRCIO DE PRODUTOS DE DIGANÓSTICOS LTDA.; CEPHEID